99mTc-amitrole as a novel selective imaging probe for solid tumor: In silico and preclinical pharmacological study

被引:42
作者
Essa, B. M. [1 ]
Sakr, T. M. [1 ]
Khedr, Mohammed A. [2 ]
El-Essawy, F. A. [3 ]
El-Mohty, A. A. [1 ]
机构
[1] Atom Energy Author EAEA, Hot Labs Ctr, Radioact Isotopes & Generator Dept, Cairo, Egypt
[2] Helwan Univ, Dept Pharmaceut Chem, Fac Pharm, Cairo 11795, Egypt
[3] Menoufia Univ, Dept Chem, Fac Sci, Shibin Al Kawm, Egypt
关键词
Amitrole; In silico; Tumor; Imaging; Hypoxia; Technetium-99m; Lactoperoxidase enzyme; CRYSTAL-STRUCTURE; LACTOPEROXIDASE; BIODISTRIBUTION; TECHNETIUM; COMPLEXES; TC-99M; AGENT;
D O I
10.1016/j.ejps.2015.05.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lactoperoxidase (LPO) inhibitors are very selective for solid tumor due to their high binding affinity to the LPO enzyme. A computational study was used to select top-ranked LPO inhibitor (alone and in complex with Tc-99m) with high in silico affinity. The novel prepared Tc-99m-amitrole complex demonstrated both in si/ico and in vivo high affinity toward solid tumors. Tc-99m-amitrole was radio-synthesized with a high radiochemical yield (89.7 +/- 3.25). It showed in vitro stability for up to 6 h. Its preclinical evaluation in solid tumor-bearing mice showed high retention and biological accumulation in solid tumor cells with a high Target/Non-Target (TINT) ratio equal to 4.9 at 60 min post-injection. The data described previously could recommend Tc-99m-amitrole as potential targeting scintigraphic probe for solid tumor imaging. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:102 / 109
页数:8
相关论文
共 40 条
  • [1] Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells
    Abrantes, Ana Margarida
    Silva Serra, Maria Elisa
    Goncalves, Ana Cristina
    Rio, Joana
    Oliveiros, Barbara
    Laranjo, Mafalda
    Rocha-Gonsalves, Antonio Manuel
    Sarmento-Ribeiro, Ana Bela
    Botelho, Maria Filomena
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (02) : 125 - 132
  • [2] [Anonymous], 2014, MOL OP ENV MOE
  • [3] Ashton A., 2011, BREAST CANC NEW INSI
  • [4] Synthesis, Characterization, and Biological Evaluation of 99mTc(CO)3-Labeled Peptides for Potential Use as Tumor Targeted Radiopharmaceuticals
    Baishya, Rinku
    Nayak, Dipak K.
    Chatterjee, Nabanita
    Halder, Kamal K.
    Karmakar, Sanmoy
    Debnath, Mita C.
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 83 (01) : 58 - 70
  • [5] Bombesin derivative radiolabeled with technetium-99m as agent for tumor identification
    Branco de Barros, Andre Luis
    Mota, Luciene das Gracas
    Ferreira, Carolina de Aguiar
    de Oliveira, Monica Cristina
    de Goes, Alfredo Miranda
    Cardoso, Valbert Nascimento
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (21) : 6182 - 6184
  • [6] Dilworth JR, 1998, CHEM SOC REV, V27, P43
  • [7] Preparation and bioevaluation of 99mTc nitrido radiopharmaceuticals with pyrazolo[1,5-a]pyrimidine as tumor imaging agents
    Ding, Rui
    He, Yong
    Xu, Jingli
    Liu, Hang
    Wang, Xiao
    Feng, Man
    Qi, Chuanmin
    Zhang, Junbo
    Peng, Cheng
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (04) : 523 - 530
  • [8] Engelhardt EL, 2002, J NUCL MED, V43, P837
  • [9] Gavhane YN., 2011, INT J PHARMA SCI RES, V2, P1, DOI DOI 10.1038/S41568-019-0209-6
  • [10] Can estrogenic radicals, generated by lactoperoxidase, be involved in the molecular mechanism of breast carcinogenesis?
    Ghibaudi, EM
    Laurenti, E
    Beltramo, P
    Ferrari, RP
    [J]. REDOX REPORT, 2000, 5 (04) : 229 - 235